News

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

Nasdaq closes compliance matter after ADS price clears threshold for 19 sessions

The closing bid price of Scinai's ADSs met or exceeded $1.00 per share from August 21, 2026 through September 17, 2026, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq had first flagged the deficiency on March 12, 2026, after the ADSs failed to maintain the $1.00 minimum over the prior 30 consecutive business days.

CEO says resolution shifts focus to CDMO commercial execution

"Receiving Nasdaq's confirmation closes an important compliance matter for Scinai,

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

FDA sets January 28, 2027 decision date under Priority Review

The Priority Review designation applies to therapies that could offer significant improvement in safety or efficacy for serious conditions. Insmed said full approval would allow ARIKAYCE, administered via PARI Pharma's Lamira Nebulizer System, to reach patients earlier in their disease course, including newly diagnosed cases and those with recurrent infections.

Germantown, Md. – September 21, 2026 -- The U.S. Food and Drug Administration has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, the technology underlying the company's first commercial product, PAPZIMEOS, approved in August 2025 for recurrent respiratory papillomatosis (RRP) in adults.

FDA designation opens accelerated pathway for future AdenoVerse cancer programs

The designation allows Precigen to leverage manufacturing and preclinical data generated for PAPZIMEOS to support future marketing applications for other AdenoVerse-based candidates, reducing duplicative development work. It also grants the company earlier and more frequent FDA engagement and allows regulators to consider prior manufacturing inspections when reviewing future applications.

Los Angeles – September 21, 2026 -- Fluxnium, Inc. has closed a $7 million seed round led by Congruent Ventures to commercialize technology that adsorbs uranium directly from seawater, targeting a domestic alternative to mined ore for nuclear fuel supply. Constellation Technology Ventures, the venture arm of Constellation (NASDAQ: CEG), and Active Impact Investments, Canada's largest climate tech seed fund, also participated in the round.

Seawater holds roughly 1,000 times more uranium than all identified land deposits combined

Fluxnium's proprietary high-surface-area fiber, developed in partnership with a U.S. national laboratory, passively captures dissolved uranium as seawater flows through it. The fiber deploys on longline systems in open water, the same passive infrastructure used in commercial seaweed and mussel farming, then is retrieved, processed and redeployed.

Dallas – September 21, 2026 -- enCore Energy Corp. (NASDAQ, TSXV: EU) has engaged North Star Investor Relations Inc. under a consulting agreement effective September 18, 2026, paying a monthly cash retainer of CAD $10,000 for shareholder outreach, capital markets intelligence and media coordination.

North Star retainer runs for one year with a 30-day termination clause

The initial term of the Consulting Agreement is one year, renewable by mutual agreement, and either party may terminate on 30 days' written notice. North Star is owned by Graham Farrell and operates from Toronto; the firm and its principals are at arm's length to enCore and held no company securities when the agreement was signed. The engagement remains subject to TSXV approval.

Johnston, Iowa and Ghent, Belgium – September 21, 2026 -- Vylor, the seed and genetics company set to spin off from Corteva on October 1, 2026, has partnered with Belgium's Rainbow Crops to develop climate-resilient corn traits using AI-driven multiplex gene editing.

Rainbow Crops' Trait Foundry platform edits hundreds of genes simultaneously

The collaboration will deploy Rainbow Crops' AI-supported Trait Foundry™ technology, which combines multiplex genome editing, precision breeding and automated phenotyping to accelerate development of corn hybrids resistant to heat, drought and flooding. Mat Muller, who will lead Vylor Edge, Vylor's investment arm, said the platform allows scientists to make hundreds of gene edits simultaneously while validating performance through phenotyping facilities and field trials.

Chicago – September 21, 2026 -- FutureSports has signed an exclusive agreement with Major League Baseball to build rules-based performance indexes on all 30 MLB clubs, clearing the path for CME Group to list cash-settled futures contracts tied to the sport for the first time.

MLB Data Feeds New CME FSPI Benchmarks Covering All 30 Clubs

Under the agreement, MLB will supply FutureSports with Official League Data, which the index administrator will convert into CME FutureSports Performance Indexes (FSPI) tracking cumulative team performance. CME Group plans to list weekly, monthly and quarterly cash-settled futures contracts on the benchmarks, subject to regulatory review.

Houston – September 21, 2026 -- McDermott International, Ltd has completed a comprehensive refinancing package worth more than $1 billion, combining a $500 million equity rights offering, a $550 million senior secured Nordic bond and a new long-term letter of credit facility.

Rights offering draws 97% shareholder subscription

The $500 million equity financing was structured as a rights offering to existing shareholders and was 97% subscribed by Class A ordinary shareholders. Remaining shares were absorbed through related backstop commitments, ensuring full completion of the raise.

Nordic bond matures in 2031, extends debt maturity profile

McDermott issued $550 million in senior secured bonds in the Nordic market, with maturity set for 2031. The company also secured a new long-term letter of credit and guarantee facility, alongside a revolving credit facility, as part of the same transaction.

Jupiter, Fla. – September 21, 2026 -- Bloomberg Television will broadcast a new episode of "Advancements with Ted Danson" on Saturday, September 26, 2026, at 8:00 p.m. ET, featuring four segments on construction technology, food packaging recyclability, continuous healthcare, and industrial automation.

Construction industry adopts AI and automation to accelerate megaproject delivery

The episode opens by examining how demand for semiconductor fabrication plants, clean energy projects, and transportation infrastructure is pushing the construction sector to build faster and at greater scale. The segment features Bechtel and shows how artificial intelligence, automation, and project data tools are being deployed to support craft professionals, engineers, and project managers.

Delray Beach, Fla. – September 21, 2026 -- The global rubber process oil (RPO) market is set to expand from $3.30 billion in 2026 to $3.94 billion by 2031, growing at a compound annual growth rate of 3.6%, according to a new report from MarketsandMarkets.

Tire manufacturing drives largest share of oil demand

The tires application segment is projected to register the highest growth at 4.7% CAGR and remains the largest consumer of RPO by value. Manufacturers rely on process oils to balance flexibility, durability, and processing efficiency across passenger, commercial, and specialty tire production. Rising replacement-tire demand and evolving fuel-efficiency standards are reinforcing this consumption base.